Identification of novel mutations of Insulin Receptor Substrate 1 (IRS1) in tumor samples of non-small cell lung cancer (NSCLC): Implications for aberrant insulin signaling in development of cancer.

Gorgisen G., HAPIL F., YILMAZ O., CETIN Z., PEHLIVANOGLU S., OZBUDAK I., ...Daha Fazla

Genetics and molecular biology, cilt.42, ss.15-25, 2019 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 42
  • Basım Tarihi: 2019
  • Doi Numarası: 10.1590/1678-4685-gmb-2017-0307
  • Dergi Adı: Genetics and molecular biology
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.15-25
  • Anahtar Kelimeler: IRS1, NSCLC, insulin signaling, lung cancer, IRS proteins, GROWTH-FACTOR RECEPTOR, ACTIVATING MUTATIONS, DOWN-REGULATION, PHOSPHORYLATION, EXPRESSION, INSULIN-RECEPTOR-SUBSTRATE-1, PROTEINS, AKT, CHEMOTHERAPY, ASSOCIATION
  • Van Yüzüncü Yıl Üniversitesi Adresli: Evet